These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21296388)

  • 21. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
    Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
    Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer.
    Naselli A; Introini C; Bertolotto F; Spina B; Puppo P
    BJU Int; 2010 Jan; 105(2):208-11. PubMed ID: 19549255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preoperative marker panel for the prediction of residual tumor and the decision making for repeat transurethral resection.
    Liu W; Qi L; Zu X; Li Y; He W; Tong S; Chen M
    Urol Oncol; 2015 Apr; 33(4):165.e9-14. PubMed ID: 25683603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre].
    Otto W; Fritsche HM; Dirmeyer M; Burger M; Straub M; Rössler W; Wieland WF; Denzinger S
    Aktuelle Urol; 2010 Sep; 41(5):316-9. PubMed ID: 20669097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
    Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
    BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Early diagnostics of bladder cancer recurrence with fluorescence in situ hybridization method in the first 24 months after a transurethral resection of a bladder in old and elderly persons].
    Pushkin AS; Ryzhak GA
    Adv Gerontol; 2012; 25(4):745-8. PubMed ID: 23734524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morphological results of repeated transurethral resection of the bladder for muscle-non-invasive cancer].
    Seregin IV; Seregin AV; Dadashev ÉO; Polozhentsev OB; Loran OB
    Urologiia; 2013; (6):77-80. PubMed ID: 24649770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective evaluation of second transurethral resection in non-muscle invasive bladder tumors.
    Aydin M; Tandogdu Z; Kurtulus FO; Avci E; Fazlioglu A; Cek M
    J BUON; 2010; 15(3):514-7. PubMed ID: 20941820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma].
    Kanematsu A; Tsuji Y; Kanba H; Noguchi T; Kamoto T; Okabe T
    Hinyokika Kiyo; 2001 Jan; 47(1):1-4. PubMed ID: 11235213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermediate-risk urothelial carcinoma: an unresolved problem?
    Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
    Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
    Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
    J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer.
    Guevara A; Salomon L; Allory Y; Ploussard G; de la Taille A; Paul A; Yiou R; Hoznek A; Dahan M; Abbou CC; Vordos D
    J Urol; 2010 Jun; 183(6):2161-4. PubMed ID: 20399454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
    Ugurlu O; Gonulalan U; Adsan O; Kosan M; Oztekin V; Cetinkaya M
    Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The application of fluorescence in situ hybridization and automated image cytometry in the diagnosis of urothelial carcinoma of bladder].
    Gu SY; Yong YS; Wang YH; Du YJ
    Zhonghua Wai Ke Za Zhi; 2010 Jun; 48(12):933-6. PubMed ID: 21055231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fluorescent endoscopy superior to white light endoscopy. Detecting cancers of the urinary bladder earlier].
    Zaak D
    MMW Fortschr Med; 2002 Mar; 144(13):24-6. PubMed ID: 12001582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The recurrence of urothelial carcinoma in situ at the fossa navicularis of the urethra and the glans penis arising eight years after transurethral resection of a bladder tumor to treat superficial bladder cancer].
    Nishizawa S; Inagaki T; Mori T; Kohjimoto Y; Suzuki A; Uekado Y; Shinka T
    Hinyokika Kiyo; 2006 Mar; 52(3):223-6. PubMed ID: 16617879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.